Nagakubo, Yuki
Hirotsu, Yosuke https://orcid.org/0000-0002-8002-834X
Amemiya, Kenji
Mochizuki, Hitoshi
Tsutsui, Toshiharu
Kakizaki, Yumiko
Miyashita, Yoshihiro
Higuchi, Rumi
Nakagomi, Takahiro
Goto, Taichiro
Oyama, Toshio
Omata, Masao
Funding for this research was provided by:
Japan Society for the Promotion of Science London (20H03668, 18K16292)
Uehara Memorial Foundation
Takeda Medical Research Foundation
Kato Memorial Bioscience Foundation
Yasuda Memorial Medical Foundation
Article History
Accepted: 27 April 2023
First Online: 17 May 2023
Declarations
:
: This study was supported by a Grant-in-Aid for the Genome Research Project from Yamanashi Prefecture (to M.O. and Y.H.), the Japan Society for the Promotion of Science KAKENHI Early-Career Scientists JP18K16292 (to Y.H.), a Grant-in-Aid for Scientific Research (B) 20H03668 and 23H02955 (to Y.H.), a Research Grant for Young Scholars (to Y.H.), the YASUDA Medical Foundation (to Y.H.), the Uehara Memorial Foundation (to Y.H.), Medical Research Grants from the Takeda Science Foundation (to Y.H.), and Kato Memorial Bioscience Foundation (to Y.H.).
: Yuki Nagakubo, Yosuke Hirotsu, Kenji Amemiya, Hitoshi Mochizuki, Toshiharu Tsutsui, Yumiko Kakizaki, Yoshihiro Miyashita, Rumi Higuchi, Takahiro Nakagomi, Taichiro Goto, Toshio Oyama, and Masao Omata have no conflicts of interest that are directly relevant to the content of this article.
: The Institutional Review Board of the Clinical Research and Genome Research Committee at Yamanashi Central Hospital approved this study and the use of an opt-out consent method (approval number: G 2018-4). This study was performed in accordance with the Declaration of Helsinki.
: The requirement for written informed consent was waived by The Institutional Review Board of the Clinical Research and Genome Research Committee at Yamanashi Central Hospital because of the retrospective nature of the study.
: Not applicable.
: All data generated or analyzed during this study are included in this published article.
: Not applicable.
: Y.N. performed the Oncomine Dx Target Test, data analysis, data collection, and manuscript preparation. Y.H. drafted the manuscript, and performed the data collection, data visualization, data interpretation, and statistical analyses. K.A. performed the Oncomine Dx Target Test and data collection. H.M. supervised and organized this study. T.T., Y.K., Y.M., R.H., T.N., and T.G. collected samples and interpreted the clinical data. T.O. assessed the diagnosis, pathologic classification and tumor content of lung cancer. M.O. conceptualized the study design and revised the manuscript. All authors reviewed and approved the manuscript.